The company that hiked the price of Daraprim, a drug used to treat AIDS patients, is backing off.
Pharmaceutical company Turing increased the price of a drug called Daraprim from $13.50 to $750 a pill and its CEO, Martin Shkreli, quickly became the focus of public anger. The over 4,000% increase also caught the eye of Hillary Clinton. She tweeted about it Monday, saying she wanted to put an end to drug "price gouging."
Martin Shkreli, Turing Pharmaceuticals CEO, lowering price of $750 AIDS drug Daraprim - Sep. 22, 2015
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.